Stress is a natural and often adaptive response to challenging or threatening situations. However, not all stress responses are the same. While many people experience short-term reactions to stressful events, others may develop longer-lasting psychological difficulties. Two commonly confused responses are acute stress and post-traumatic stress disorder (PTSD). The key difference lies in duration, severity, and the presence of trauma-specific symptoms. Understanding the differences between them is essential for recognising when support or treatment may be needed.
Acute stress refers to the immediate psychological and physiological response to a perceived threat or challenging situation. This response is often described as the “fight, flight, or freeze” response and is mediated by the body’s stress system, including the release of hormones such as adrenaline and cortisol.
Common symptoms of acute stress include:
These symptoms are typically short-lived, lasting from minutes to several days, though this can vary depending on the situation. In many cases, acute stress can be beneficial, helping individuals respond effectively to immediate challenges (McEwen, 2007).
Post-traumatic stress disorder (PTSD) is a mental health condition that can develop after exposure to a traumatic event, such as serious injury, violence, or life-threatening situations. Unlike acute stress, PTSD involves persistent and distressing symptoms that continue well beyond the initial event.
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), PTSD is diagnosed when a person has experienced a traumatic event followed by persistent symptoms of intrusion, avoidance, negative changes in mood or cognition, and increased arousal lasting over one month, causing significant distress or impairment and not attributable to substance use or another medical condition (American Psychiatric Association, 2022).
Core symptoms of PTSD include:
PTSD is not simply an extended stress response, it involves changes in how the brain processes fear and memory, often leading to ongoing distress and functional impairment (Brewin et al., 2000).
|
Feature |
Acute Stress |
PTSD |
|
Onset |
Immediately after a stressor; can occur after everyday stressors or major life events |
Follows exposure to a traumatic event (e.g., serious injury, assault, combat, natural disaster); may begin soon after the trauma or emerge weeks to months later (sometimes with delayed expression). |
|
Duration |
Short-term, typically minutes to days |
Persistent, lasting more than 1 month; symptoms can continue for years if untreated |
|
Severity |
Usually mild to moderate; physiological arousal is temporary |
Often severe and clinically impairing; symptoms interfere with personal, social, and occupational functioning |
|
Symptoms |
General stress response: heart palpitations, nausea, anxiety, heightened alertness, sleep disturbance, difficulty concentrating, muscle tension |
Trauma-specific symptoms: intrusive memories/flashbacks, nightmares, avoidance of reminders, negative changes in mood and cognition, hyperarousal, exaggerated startle response |
|
Neurobiology |
Activation of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system; short-term cortisol and adrenaline surge |
Altered regulation of the HPA axis, altered amygdala and hippocampal function, and persistent hyperarousal or emotional dysregulation |
|
Impact on daily life |
Usually temporary disruption; functioning returns to baseline once stressor resolves |
Significant, long-term impairment in work, relationships, and daily functioning |
It is important to note that some individuals may experience acute stress disorder (ASD), which includes trauma-related symptoms lasting between 3 days and 1 month. PTSD may be diagnosed if symptoms persist beyond this period (Bryant, 2017; Barnhill and Zimmerman, 2023).
Most cases of acute stress are self-limiting and resolve naturally without formal intervention. Treatment focuses on symptom relief, emotional support and may help reduce the risk of developing longer term conditions such as ASD or PTSD.
Helpful strategies include:
PTSD is a long-lasting condition that typically requires evidence-based interventions to reduce symptoms and improve daily functioning.
Primary psychological treatments include:
Pharmacological options:
Emerging treatments and adjunctive approaches:
It is normal to feel stressed after a difficult or traumatic experience. However, professional support may be beneficial if:
Early intervention can play a key role in improving outcomes and preventing chronic symptoms.
Acute stress and PTSD exist on a spectrum of stress responses but differ significantly in duration, severity, and impact. While acute stress is typically short-lived and adaptive, PTSD is a longer-term condition that requires clinical attention. Recognising these differences can help individuals seek appropriate support and access effective treatment when needed.
Written by Holly, Smart TMS Newcastle practitioner
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).
American Psychological Association. (2023, December 21). What is EMDR therapy and why is it used to treat PTSD? https://www.apa.org/topics/psychotherapy/emdr-therapy-ptsd
Barnhill, J. W., & Zimmerman, M. (2023). Acute stress disorder (ASD). In MSD Manual Professional Edition. Merck & Co., Inc. https://www.msdmanuals.com/professional/psychiatric-disorders/anxiety-and-stressor-related-disorders/acute-stress-disorder-asd#Treatment_v11688273
Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 68(5), 748–766.
Bryant, R. A. (2017). Acute stress disorder as a predictor of posttraumatic stress disorder: A systematic review. Journal of Clinical Psychiatry, 78(4), e426–e431.
Ennis, N., Sijercic, I., & Monson, C. M. (2021). Trauma-focused cognitive-behavioural therapies for posttraumatic stress disorder under ongoing threat: A systematic review. Clinical Psychology Review, 88, 102049.
McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation. Physiological Reviews, 87(3), 873–904.
McLean, C. P., & Foa, E. B. (2011). Prolonged exposure therapy for post-traumatic stress disorder: A review of evidence and dissemination. Expert Review of Neurotherapeutics, 11(8), 1151–1163.
National Centre for PTSD. (2023). Clinician’s guide to medications for PTSD. U.S. Department of Veterans Affairs. https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp
World Health Organization. (2023). Medications used in PTSD. OurMental.Health. https://www.ourmental.health/trauma/world-health-organization-ptsd-management-guidelines
Yan, T., Xie, Q., Zheng, Z., Zou, K., & Wang, L. (2017). Different frequency repetitive transcranial magnetic stimulation (rTMS) for posttraumatic stress disorder (PTSD): A systematic review and meta-analysis. Journal of Psychiatric Research, 89, 125–135.